Feedback / Questions
ENV-294 - Enveda Biosci
https://www.businesswire.com/news/home/20251209287981/en/Enveda-Initiates-Phase-2-Clinical-Trials-of-ENV-294-a-First-in-Class-Oral-Therapy-in-Atopic-Dermatitis-and-Asthma
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next